Oruka Therapeutics stock forecast
Want to see ORKA full AI Analyst Report?
Oruka Therapeutics (ORKA) Stock Forecast & Price Target
ORKA Analyst Ratings
ORKA Stock 12 Month Forecast
Average Price Target
$153.60▲(45.80% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Etzer Darout | Barclays | $160 | buy | 51.87%Upside | Reiterated | 11/10/26 | ||
| Mitchell Kapoor | H.C. Wainwright | $120 | buy | 13.91%Upside | Reiterated | 11/10/26 | ||
| Alex Thompson CFA | Stifel Nicolaus | $150 | buy | 42.38%Upside | Reiterated | 11/10/26 | ||
| Yasmeen Rahimi | Piper Sandler | $180 | buy | 70.86%Upside | Reiterated | 11/10/26 | ||
| Michael Yee | UBS | $130 | buy | 23.40%Upside | Reiterated | 11/10/26 | ||
| Julian Harrison | BTIG | $151 | buy | 43.33%Upside | Reiterated | 11/09/26 | ||
| Guggenheim | $200 | buy | 89.84%Upside | Reiterated | 11/09/26 | |||
| Martin Fan | Wedbush | $165 | buy | 56.62%Upside | Reiterated | 10/27/26 | ||
| David Risinger | Leerink Partners | ― | buy | ― | Reiterated | 10/27/26 | ||
| Kaveri Pohlman | Clear Street | $131→$105 | buy | -0.33%Downside | Reiterated | 10/26/26 | ||
| Sam Slutsky | LifeSci Capital | $175 | buy | 66.11%Upside | Reiterated | 09/23/26 | ||
| Tyler Van Buren | TD Cowen | ― | buy | ― | Reiterated | 08/26/26 | ||
| Roger Song | Jefferies | $133 | buy | 26.25%Upside | Reiterated | 08/11/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Etzer DaroutBarclays | BuyReiterated$160 | 11/10/26 | 51.87%Upside | ||
| Mitchell KapoorH.C. Wainwright | BuyReiterated$120 | 11/10/26 | 13.91%Upside | ||
| Alex Thompson CFAStifel Nicolaus | BuyReiterated$150 | 11/10/26 | 42.38%Upside | ||
| Yasmeen RahimiPiper Sandler | BuyReiterated$180 | 11/10/26 | 70.86%Upside | ||
| Michael YeeUBS | BuyReiterated$130 | 11/10/26 | 23.40%Upside | ||
| Julian HarrisonBTIG | BuyReiterated$151 | 11/09/26 | 43.33%Upside | ||
| BuyReiterated$200 | 11/09/26 | 89.84%Upside | |||
| Martin FanWedbush | BuyReiterated$165 | 10/27/26 | 56.62%Upside | ||
| David RisingerLeerink Partners | BuyReiterated | 10/27/26 | ― | ||
| Kaveri PohlmanClear Street | BuyReiterated$131→$105 | 10/26/26 | -0.33%Downside | ||
| Sam SlutskyLifeSci Capital | BuyReiterated$175 | 09/23/26 | 66.11%Upside | ||
| Tyler Van BurenTD Cowen | BuyReiterated | 08/26/26 | ― | ||
| Roger SongJefferies | BuyReiterated$133 | 08/11/26 | 26.25%Upside |
Best Analysts Covering Oruka Therapeutics
Copying Julian Harrison's trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +53.48% per trade.
Copying Mitchell Kapoor's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +197.49% per trade.
Copying David Risinger's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +419.88% per trade.
ORKA Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 14 | 13 | 13 | 17 | 13 |
| Buy | 4 | 7 | 9 | 11 | 11 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 18 | 20 | 22 | 28 | 24 |
In the current month, ORKA has received 24 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORKA average Analyst price target in the past 3 months is 153.60.
ORKA Financial Forecast
ORKA Earnings Forecast
Next quarter’s earnings estimate for ORKA is -$0.75 with a range of -$1.00 to -$0.60. The previous quarter’s EPS was -$0.63. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
ORKA Sales Forecast
Next quarter’s sales forecast for ORKA is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

